News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Invitrogen Corporation (IVGN) And Cellartis AB Collaborate To Create hESC Multi-Lineage Reporter Lines


6/28/2006 4:18:31 PM

Invitrogen Corporation (Nasdaq:IVGN - News) and Cellartis AB today announced a collaboration between the companies to develop novel engineered human embryonic stem cell (hESC) reporter lines. The collaboration will bring together Invitrogen's platform technologies and expertise in molecular and cellular biology, labeling and detection and cell culture and Cellartis' expertise in deriving and growing hESC lines. These lines will, for the first time, provide scientists with a visual readout for tracking stem cell differentiation into different lineages and also enable scientists to study multiple genes involved in differentiation pathways, without having to sacrifice the cells. Financial terms of the collaboration were not disclosed.

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES